PubMed ID:
19064853
Public Release Type:
Journal
Publication Year: 2008
Affiliation: Diabetes Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
DOI:
https://doi.org/10.1001/archopht.126.12.1707
Authors:
Cleary PA,
Danis RP,
Davis MD,
Hainsworth DP,
Hubbard LD,
Lachin JM,
Nathan DM,
Sun W,
White NH
To examine the persistence of the original treatment effects 10 years after the Diabetes Control and Complications Trial (DCCT) in the follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study. In the DCCT, intensive therapy aimed at near-normal glycemia reduced the risk of microvascular complications of type 1 diabetes mellitus compared with conventional therapy.